The case for CBT over antidepressants

P Jane Wilson
Med J Aust 2014; 200 (8): . || doi: 10.5694/mja13.10716
Published online: 5 May 2014

To the Editor: In her book review,1 Wilhelm fails to comment on the central theme of Paul Biegler's The ethical treatment of depression: autonomy through psychotherapy.2 Biegler argues that clinicians have a moral duty to promote psychological therapies (including cognitive behaviour therapy) to individuals with uncomplicated depression, over and above antidepressant medications (ADMs). He reasons that patient autonomy and empowerment — surely central concerns for every physician — are most likely achieved with talking therapies, rather than drug treatment.

  • P Jane Wilson

  • Launceston, TAS.

Competing interests:

I am a member of the planning group of Healthy Skepticism, an international non-profit organisation whose main aim is to improve health by reducing harm from misleading drug promotion.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.